Relationship between oxygen partial pressure and inhibition of cell aggregation of human adipose tissue-derived mesenchymal stem cells stored in cell preservation solutions
- PMID: 37303463
- PMCID: PMC10247950
- DOI: 10.1016/j.reth.2023.05.002
Relationship between oxygen partial pressure and inhibition of cell aggregation of human adipose tissue-derived mesenchymal stem cells stored in cell preservation solutions
Abstract
Introduction: This study investigated the storage conditions under which cell aggregation occurs and the conditions that inhibit cell aggregation when human adipose tissue-derived mesenchymal stem cells (hADSCs) are stored in lactated Ringer's solution (LR) supplemented with 3% trehalose and 5% dextran 40 (LR-3T-5D).
Methods: We first examined the effects of storage temperature and time on the aggregation and viability of hADSCs stored in LR and LR-3T-5D. The cells were stored at 5 °C or 25 °C for various times up to 24 h. We then evaluated the effects of storage volume (250-2,000 μL), cell density (2.5-20 × 105 cells/mL), and nitrogen gas replacement on aggregation, oxygen partial pressure (pO2), and viability of hADSCs stored for 24 h at 25 °C in LR-3T-5D.
Results: When stored in LR-3T-5D, viability did not change under either condition compared with pre-storage, but the cell aggregation rate increased significantly with storage at 25 °C for 24 h (p<0.001). In LR, the aggregation rate did not change under either condition, but cell viability decreased significantly after 24 h at both 5 °C and 25 °C (p < 0.05). The cell aggregation rates and pO2 tended to decrease with increasing solution volume and cell density. Nitrogen gas replacement significantly decreased the cell aggregation rate and pO2 (p < 0.05). However, there were no differences in viability among cells stored under conditions of different storage volumes, densities, and nitrogen gas replacement.
Conclusions: Aggregation of cells after storage at 25 °C in LR-3T-5D may be suppressed by increasing the storage volume and cell density as well as by incorporating nitrogen replacement, which lowers the pO2 in the solution.
Keywords: Cell aggregation; Cell preservation solution; Human adipose tissue–derived mesenchymal stem cell; Oxygen partial pressure.
© 2023 The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.
Conflict of interest statement
The experimental work presented in this article was performed while T. Kikuchi, M. Nishimura, C. Shirakawa, and Y. Fujita were employed at Otsuka Pharmaceutical Factory, Inc. T. Otoi has no financial interest. Non-financial interest: none.
Figures





Similar articles
-
A pair of cell preservation solutions for therapy with human adipose tissue-derived mesenchymal stromal cells.Regen Ther. 2020 Jan 16;14:95-102. doi: 10.1016/j.reth.2019.10.004. eCollection 2020 Jun. Regen Ther. 2020. PMID: 31988999 Free PMC article.
-
Protein-free solution containing trehalose and dextran 40 for cryopreservation of human adipose tissue-derived mesenchymal stromal cells.Cryobiology. 2021 Jun;100:46-57. doi: 10.1016/j.cryobiol.2021.03.011. Epub 2021 Apr 3. Cryobiology. 2021. PMID: 33823188
-
Ascorbic acid enhances the cold preservation period of human adipose tissue-derived mesenchymal stromal cells.Regen Ther. 2023 Jun 28;24:154-160. doi: 10.1016/j.reth.2023.06.008. eCollection 2023 Dec. Regen Ther. 2023. PMID: 37868720 Free PMC article.
-
Dimethyl sulfoxide-free cryopreservation solution containing trehalose, dextran 40, and propylene glycol for therapy with human adipose tissue-derived mesenchymal stromal cells.Cytotechnology. 2022 Oct;74(5):515-529. doi: 10.1007/s10616-022-00541-3. Epub 2022 Aug 12. Cytotechnology. 2022. PMID: 36238270 Free PMC article.
-
Effects of carrier solutions on the viability and efficacy of canine adipose-derived mesenchymal stem cells.BMC Vet Res. 2022 Jan 7;18(1):26. doi: 10.1186/s12917-021-03120-4. BMC Vet Res. 2022. PMID: 34996443 Free PMC article.
References
-
- Munir H., McGettrick H.M. Mesenchymal stem cell therapy for autoimmune disease: risks and rewards. Stem Cells Dev. 2015;24(18):2091–2100. - PubMed
LinkOut - more resources
Full Text Sources